Why Is Cerevel Therapeutics Holdings, Inc. (CERE) One of the Best Healthcare Stocks to Buy Under $50? [Yahoo! Finance]
Cerevel Therapeutics Holdings, Inc. (CERE)
Company Research
Source: Yahoo! Finance
Therapeutics Holdings, Inc. (NASDAQ:CERE) stands against the other healthcare stocks under $50. If interested, you can also read our recent article on the 10 Best Healthcare Stocks To Buy According to Hedge Funds According to Michael Adams, the Lead Editor of Investing at Forbes, investments in healthcare stocks provide investors with consistent and steady returns because of the defensive nature of these stocks. No matter what the economic situation or direction of the stock market, people will always need healthcare and medical services. The healthcare industry is thriving in the United States. A recent report highlighted a 7.5% increase in healthcare spending in the country in 2023, which was higher than the nominal GDP growth rate during the same year. The percentage of Americans with health insurance reached a record high of 93.1%, contributing to the high growth in healthcare expenditure last year. Between 2023 and 2032, the national healthcare spending in the United States i
Show less
Read more
Impact Snapshot
Event Time:
CERE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CERE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CERE alerts
High impacting Cerevel Therapeutics Holdings, Inc. news events
Weekly update
A roundup of the hottest topics
CERE
News
- The Schall Law Firm Is Undertaking An Investigation Into Cerevel Therapeutics Holdings Inc And Holders Of CERE Stocks Are Encouraged To ParticipateAccesswire
- The Schall Law Firm Is Conducting A Probe Into Cerevel Therapeutics Holdings Inc And Shareholders Of CERE Are Invited To JoinAccesswire
- The Schall Law Firm Is Conducting A Probe Into Cerevel Therapeutics Holdings Inc And Owners Of CERE Shares Are Invited To JoinAccesswire
- CEREVEL (NASDAQ:CERE) ACQUISITION ALERT: Cerevel's $45 Per Share Deal is Being Investigated by BFA Law, Shareholders are Notified to Contact the FirmAccesswire
- The Schall Law Firm Is Embarking On A Probe Into Cerevel Therapeutics Holdings Inc And CERE Shareholders Are Invited To JoinAccesswire
CERE
Earnings
- 5/8/24 - Miss
CERE
Sec Filings
- 6/7/24 - Form 4
- 6/7/24 - Form 4
- 6/7/24 - Form 4
- CERE's page on the SEC website